Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Baxter International Inc.    BAX

BAXTER INTERNATIONAL INC.

(BAX)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Baxter International : to Buy Cheetah Medical for Up to $230 Million

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/10/2019 | 07:53am EDT

By Colin Kellaher

Baxter International Inc. (BAX) Tuesday said it agreed to buy Cheetah Medical, a provider of non-invasive hemodynamic monitoring technologies, for up to $230 million.

The Deerfield, Ill., medical-products company said it will pay $190 million cash at closing, along with up to an additional $40 million based on clinical and commercial milestones.

Baxter said the acquisition accelerates its presence in the specialized patient-monitoring space with technology used to guide fluid management.

Baxter said it expects to complete the acquisition in the fourth quarter, adding that the deal will be immaterial to earnings in 2019 and 2020.

Write to Colin Kellaher at colin.kellaher@wsj.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAXTER INTERNATIONAL INC.
09/10BAXTER INTERNATIONAL : to Buy Cheetah Medical for Up to $230 Million
DJ
09/10BAXTER INTERNATIONAL : Announces Acquisition of Cheetah Medical to Expand Specia..
BU
09/04BAXTER INTERNATIONAL : to Host Third Quarter 2019 Financial Results Conference C..
BU
08/29BAXTER INTERNATIONAL : Launches Olimel N12 In Europe to Meet High Protein Needs ..
BU
08/29BAXTER INTERNATIONAL INC. : Ex-dividend day for
FA
08/21BAXTER INTERNATIONAL : Foundation and Direct Relief Launch Program to Improve Di..
BU
08/20BAXTER INTERNATIONAL : Bis Henderson recruits senior practitioner to Executive S..
AQ
08/20BAXTER INTERNATIONAL INC. : Report
CO
08/15BAXTER INTERNATIONAL : and COSMED Announce Partnership to Bring Next-generation ..
BU
08/14BAXTER INTERNATIONAL : to Present at the Morgan Stanley 17th Annual Global Healt..
BU
More news
Financials (USD)
Sales 2019 11 300 M
EBIT 2019 2 050 M
Net income 2019 1 575 M
Debt 2019 1 271 M
Yield 2019 0,96%
P/E ratio 2019 29,1x
P/E ratio 2020 24,4x
EV / Sales2019 4,04x
EV / Sales2020 3,87x
Capitalization 44 383 M
Chart BAXTER INTERNATIONAL INC.
Duration : Period :
Baxter International Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAXTER INTERNATIONAL INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 91,44  $
Last Close Price 86,93  $
Spread / Highest target 20,8%
Spread / Average Target 5,19%
Spread / Lowest Target -20,6%
EPS Revisions
Managers
NameTitle
José E. Almeida Chairman, President & Chief Executive Officer
Scott Pleau Vice President-Operations
James K. Saccaro Chief Financial Officer & Executive Vice President
Paul E. Martin Chief Information Officer & Vice President
Sumant Ramachandra Senior VP, Chief Science & Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
BAXTER INTERNATIONAL INC.32.07%44 383
MEDTRONIC PLC20.57%147 141
HOYA CORPORATION37.15%30 886
ZIMMER BIOMET HOLDINGS33.81%28 496
TERUMO CORP-47.51%21 925
ALIGN TECHNOLOGY-15.26%14 175